Detalhe da pesquisa
1.
Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study.
Am J Gastroenterol
; 118(7): 1248-1255, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622356
2.
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study).
Eur J Cancer
; 144: 61-71, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340853